Cargando…

The Effect of Angiotensin Converting Enzyme (ACE) I/D Polymorphism on Atherosclerotic Cardiovascular Disease and Cardiovascular Mortality Risk in Non-Hemodialyzed Chronic Kidney Disease: The Mediating Role of Plasma ACE Level

The association between angiotensin-converting enzyme insertion/deletion (ACE I/D) polymorphisms and plasma ACE levels may allow for the optimization of a preventive intervention to reduce cardiovascular morbidity and mortality in the chronic kidney disease (CKD) population. In this study, we aimed...

Descripción completa

Detalles Bibliográficos
Autores principales: Susilo, Hendri, Pikir, Budi Susetyo, Thaha, Mochammad, Alsagaff, Mochamad Yusuf, Suryantoro, Satriyo Dwi, Wungu, Citrawati Dyah Kencono, Wafa, Ifan Ali, Pakpahan, Cennikon, Oceandy, Delvac
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318243/
https://www.ncbi.nlm.nih.gov/pubmed/35885904
http://dx.doi.org/10.3390/genes13071121
_version_ 1784755243626528768
author Susilo, Hendri
Pikir, Budi Susetyo
Thaha, Mochammad
Alsagaff, Mochamad Yusuf
Suryantoro, Satriyo Dwi
Wungu, Citrawati Dyah Kencono
Wafa, Ifan Ali
Pakpahan, Cennikon
Oceandy, Delvac
author_facet Susilo, Hendri
Pikir, Budi Susetyo
Thaha, Mochammad
Alsagaff, Mochamad Yusuf
Suryantoro, Satriyo Dwi
Wungu, Citrawati Dyah Kencono
Wafa, Ifan Ali
Pakpahan, Cennikon
Oceandy, Delvac
author_sort Susilo, Hendri
collection PubMed
description The association between angiotensin-converting enzyme insertion/deletion (ACE I/D) polymorphisms and plasma ACE levels may allow for the optimization of a preventive intervention to reduce cardiovascular morbidity and mortality in the chronic kidney disease (CKD) population. In this study, we aimed to analyze the association between ACE I/D polymorphism and cardiovascular mortality risk among non-hemodialyzed chronic kidney disease patients. This cross-sectional study examined 70 patients of Javanese ethnic origin with stable CKD who did not receive hemodialysis. ACE I/D polymorphisms, plasma ACE levels, atherosclerotic cardiovascular disease (ASCVD) risk, and cardiovascular mortality risk were investigated. As per our findings, the I allele was found to be more frequent (78.6) than the D allele (21.4), and the DD genotype was less frequent than the II genotype (4.3 vs. 61.4). The ACE I/D polymorphism had a significant direct positive effect on plasma ACE levels (path coefficient = 0.302, p = 0.021). Similarly, plasma ACE levels had a direct and significant positive effect on the risk of atherosclerotic cardiovascular disease (path coefficient = 0.410, p = 0.000). Moreover, atherosclerotic cardiovascular disease risk had a significant positive effect on cardiovascular mortality risk (path coefficient = 0.918, p = 0.000). The ACE I/D polymorphism had no direct effect on ASCVD and cardiovascular mortality risk. However, our findings show that the indirect effects of high plasma ACE levels may be a factor in the increased risk of ASCVD and cardiovascular mortality in Javanese CKD patients.
format Online
Article
Text
id pubmed-9318243
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93182432022-07-27 The Effect of Angiotensin Converting Enzyme (ACE) I/D Polymorphism on Atherosclerotic Cardiovascular Disease and Cardiovascular Mortality Risk in Non-Hemodialyzed Chronic Kidney Disease: The Mediating Role of Plasma ACE Level Susilo, Hendri Pikir, Budi Susetyo Thaha, Mochammad Alsagaff, Mochamad Yusuf Suryantoro, Satriyo Dwi Wungu, Citrawati Dyah Kencono Wafa, Ifan Ali Pakpahan, Cennikon Oceandy, Delvac Genes (Basel) Article The association between angiotensin-converting enzyme insertion/deletion (ACE I/D) polymorphisms and plasma ACE levels may allow for the optimization of a preventive intervention to reduce cardiovascular morbidity and mortality in the chronic kidney disease (CKD) population. In this study, we aimed to analyze the association between ACE I/D polymorphism and cardiovascular mortality risk among non-hemodialyzed chronic kidney disease patients. This cross-sectional study examined 70 patients of Javanese ethnic origin with stable CKD who did not receive hemodialysis. ACE I/D polymorphisms, plasma ACE levels, atherosclerotic cardiovascular disease (ASCVD) risk, and cardiovascular mortality risk were investigated. As per our findings, the I allele was found to be more frequent (78.6) than the D allele (21.4), and the DD genotype was less frequent than the II genotype (4.3 vs. 61.4). The ACE I/D polymorphism had a significant direct positive effect on plasma ACE levels (path coefficient = 0.302, p = 0.021). Similarly, plasma ACE levels had a direct and significant positive effect on the risk of atherosclerotic cardiovascular disease (path coefficient = 0.410, p = 0.000). Moreover, atherosclerotic cardiovascular disease risk had a significant positive effect on cardiovascular mortality risk (path coefficient = 0.918, p = 0.000). The ACE I/D polymorphism had no direct effect on ASCVD and cardiovascular mortality risk. However, our findings show that the indirect effects of high plasma ACE levels may be a factor in the increased risk of ASCVD and cardiovascular mortality in Javanese CKD patients. MDPI 2022-06-23 /pmc/articles/PMC9318243/ /pubmed/35885904 http://dx.doi.org/10.3390/genes13071121 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Susilo, Hendri
Pikir, Budi Susetyo
Thaha, Mochammad
Alsagaff, Mochamad Yusuf
Suryantoro, Satriyo Dwi
Wungu, Citrawati Dyah Kencono
Wafa, Ifan Ali
Pakpahan, Cennikon
Oceandy, Delvac
The Effect of Angiotensin Converting Enzyme (ACE) I/D Polymorphism on Atherosclerotic Cardiovascular Disease and Cardiovascular Mortality Risk in Non-Hemodialyzed Chronic Kidney Disease: The Mediating Role of Plasma ACE Level
title The Effect of Angiotensin Converting Enzyme (ACE) I/D Polymorphism on Atherosclerotic Cardiovascular Disease and Cardiovascular Mortality Risk in Non-Hemodialyzed Chronic Kidney Disease: The Mediating Role of Plasma ACE Level
title_full The Effect of Angiotensin Converting Enzyme (ACE) I/D Polymorphism on Atherosclerotic Cardiovascular Disease and Cardiovascular Mortality Risk in Non-Hemodialyzed Chronic Kidney Disease: The Mediating Role of Plasma ACE Level
title_fullStr The Effect of Angiotensin Converting Enzyme (ACE) I/D Polymorphism on Atherosclerotic Cardiovascular Disease and Cardiovascular Mortality Risk in Non-Hemodialyzed Chronic Kidney Disease: The Mediating Role of Plasma ACE Level
title_full_unstemmed The Effect of Angiotensin Converting Enzyme (ACE) I/D Polymorphism on Atherosclerotic Cardiovascular Disease and Cardiovascular Mortality Risk in Non-Hemodialyzed Chronic Kidney Disease: The Mediating Role of Plasma ACE Level
title_short The Effect of Angiotensin Converting Enzyme (ACE) I/D Polymorphism on Atherosclerotic Cardiovascular Disease and Cardiovascular Mortality Risk in Non-Hemodialyzed Chronic Kidney Disease: The Mediating Role of Plasma ACE Level
title_sort effect of angiotensin converting enzyme (ace) i/d polymorphism on atherosclerotic cardiovascular disease and cardiovascular mortality risk in non-hemodialyzed chronic kidney disease: the mediating role of plasma ace level
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318243/
https://www.ncbi.nlm.nih.gov/pubmed/35885904
http://dx.doi.org/10.3390/genes13071121
work_keys_str_mv AT susilohendri theeffectofangiotensinconvertingenzymeaceidpolymorphismonatheroscleroticcardiovasculardiseaseandcardiovascularmortalityriskinnonhemodialyzedchronickidneydiseasethemediatingroleofplasmaacelevel
AT pikirbudisusetyo theeffectofangiotensinconvertingenzymeaceidpolymorphismonatheroscleroticcardiovasculardiseaseandcardiovascularmortalityriskinnonhemodialyzedchronickidneydiseasethemediatingroleofplasmaacelevel
AT thahamochammad theeffectofangiotensinconvertingenzymeaceidpolymorphismonatheroscleroticcardiovasculardiseaseandcardiovascularmortalityriskinnonhemodialyzedchronickidneydiseasethemediatingroleofplasmaacelevel
AT alsagaffmochamadyusuf theeffectofangiotensinconvertingenzymeaceidpolymorphismonatheroscleroticcardiovasculardiseaseandcardiovascularmortalityriskinnonhemodialyzedchronickidneydiseasethemediatingroleofplasmaacelevel
AT suryantorosatriyodwi theeffectofangiotensinconvertingenzymeaceidpolymorphismonatheroscleroticcardiovasculardiseaseandcardiovascularmortalityriskinnonhemodialyzedchronickidneydiseasethemediatingroleofplasmaacelevel
AT wungucitrawatidyahkencono theeffectofangiotensinconvertingenzymeaceidpolymorphismonatheroscleroticcardiovasculardiseaseandcardiovascularmortalityriskinnonhemodialyzedchronickidneydiseasethemediatingroleofplasmaacelevel
AT wafaifanali theeffectofangiotensinconvertingenzymeaceidpolymorphismonatheroscleroticcardiovasculardiseaseandcardiovascularmortalityriskinnonhemodialyzedchronickidneydiseasethemediatingroleofplasmaacelevel
AT pakpahancennikon theeffectofangiotensinconvertingenzymeaceidpolymorphismonatheroscleroticcardiovasculardiseaseandcardiovascularmortalityriskinnonhemodialyzedchronickidneydiseasethemediatingroleofplasmaacelevel
AT oceandydelvac theeffectofangiotensinconvertingenzymeaceidpolymorphismonatheroscleroticcardiovasculardiseaseandcardiovascularmortalityriskinnonhemodialyzedchronickidneydiseasethemediatingroleofplasmaacelevel
AT susilohendri effectofangiotensinconvertingenzymeaceidpolymorphismonatheroscleroticcardiovasculardiseaseandcardiovascularmortalityriskinnonhemodialyzedchronickidneydiseasethemediatingroleofplasmaacelevel
AT pikirbudisusetyo effectofangiotensinconvertingenzymeaceidpolymorphismonatheroscleroticcardiovasculardiseaseandcardiovascularmortalityriskinnonhemodialyzedchronickidneydiseasethemediatingroleofplasmaacelevel
AT thahamochammad effectofangiotensinconvertingenzymeaceidpolymorphismonatheroscleroticcardiovasculardiseaseandcardiovascularmortalityriskinnonhemodialyzedchronickidneydiseasethemediatingroleofplasmaacelevel
AT alsagaffmochamadyusuf effectofangiotensinconvertingenzymeaceidpolymorphismonatheroscleroticcardiovasculardiseaseandcardiovascularmortalityriskinnonhemodialyzedchronickidneydiseasethemediatingroleofplasmaacelevel
AT suryantorosatriyodwi effectofangiotensinconvertingenzymeaceidpolymorphismonatheroscleroticcardiovasculardiseaseandcardiovascularmortalityriskinnonhemodialyzedchronickidneydiseasethemediatingroleofplasmaacelevel
AT wungucitrawatidyahkencono effectofangiotensinconvertingenzymeaceidpolymorphismonatheroscleroticcardiovasculardiseaseandcardiovascularmortalityriskinnonhemodialyzedchronickidneydiseasethemediatingroleofplasmaacelevel
AT wafaifanali effectofangiotensinconvertingenzymeaceidpolymorphismonatheroscleroticcardiovasculardiseaseandcardiovascularmortalityriskinnonhemodialyzedchronickidneydiseasethemediatingroleofplasmaacelevel
AT pakpahancennikon effectofangiotensinconvertingenzymeaceidpolymorphismonatheroscleroticcardiovasculardiseaseandcardiovascularmortalityriskinnonhemodialyzedchronickidneydiseasethemediatingroleofplasmaacelevel
AT oceandydelvac effectofangiotensinconvertingenzymeaceidpolymorphismonatheroscleroticcardiovasculardiseaseandcardiovascularmortalityriskinnonhemodialyzedchronickidneydiseasethemediatingroleofplasmaacelevel